Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study

BACKGROUND: The goal of this research was to compare the demographics, clinical characteristics and treatment patterns for newly diagnosed multiple sclerosis (MS) patients in a commercial managed care population who received disease-modifying drug (DMD) therapy versus those not receiving DMD therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Margolis, Jay M, Fowler, Robert, Johnson, Barbara H, Kassed, Cheryl A, Kahler, Kristijan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204236/
https://www.ncbi.nlm.nih.gov/pubmed/21974973
http://dx.doi.org/10.1186/1471-2377-11-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204236/
https://www.ncbi.nlm.nih.gov/pubmed/21974973
http://dx.doi.org/10.1186/1471-2377-11-122

Ejemplares similares